During the past decade, Osaka Red Cross Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka Red Cross Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Bayer" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Kyoto University" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka Red Cross Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Japan Lung Cancer Society" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Osaka Red Cross Hospital" are "Anemia" (3 trials), "Carcinoma, Hepatocellular" (2 trials), "Colorectal Cancer" (2 trials), "HBV" (2 trials) and "Hepatitis C, Chronic" (2 trials). Many other conditions were trialed in "Osaka Red Cross Hospital" in a lesser frequency.

Most popular intervention types in "Osaka Red Cross Hospital" are "Drug" (24 trials), "Other" (2 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Lenalidomide" (4 trials), "Bortezomib" (2 trials), "Darbepoetin alfa" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Red Cross Hospital" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Osaka Red Cross Hospital". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Osaka Red Cross Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Red Cross Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".